bell
The current prices are delayed by 15 mins, login to check live prices.
RPG Life Sciences Ltd share price logo

RPG Life Sciences Ltd

(RPGLIFE)

₹26530.78%

as on 04:01PM, 07 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

RPG Life Sciences Ltd Performance

  • Day's Low

    Day's High

    ₹2,623.95
    ₹2,728.7
  • 52 Week's Low

    52 Week's High

    ₹1,292
    ₹2,974.95
1 Month Return+ 0.65 %
3 Month Return+ 37.09 %
1 Year Return+ 84.43 %
Previous Close₹2,673.90
Open₹2,727.00
Volume11.95K
Upper Circuit-
Lower Circuit-
Market Cap₹4,422.37Cr

RPG Life Sciences Ltd Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹4,422.37 Cr
P/B Ratio6.75
EPS0
Dividend Yield0
SectorPharmaceuticals
ROE25.69

RPG Life Sciences Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹4,422.37 Cr163.84%0.51NANA
NA₹472.52 Cr99.84%0.60₹5 Cr₹173 Cr
NA₹181.61 Cr64.87%0.56NANA
NA₹20.73 Cr79.9%1.86NANA
NA₹221.19 Cr63.89%0.51NANA

About RPG Life Sciences Ltd

RPG Life Sciences Ltd (formerly Searle India Ltd) began operations in 1968 as a joint venture with GD Searle USA. After 1993 GD Searle withdrew and sold its holdings to the RPG Group. The company is involved in the manufacturing and marketing of Formulations Finished Dosage Forms and Active Pharmaceutical Ingredients APIs. It has research and development facilities which are internationally compliant, such as Biotech RD API RD and Formulations RD, as well as TGA Aus and MHRA UK approved facilities in Thane in Maharashtra and Ankleshwar in Gujarat. In 2008 the equity shares of the company were listed on BSE and NSE, and in 2009-2010 the company increased the production capacity of Bulk Drugs and Chemicals from 62 to 71 tonnes. They launched an oncology drug, Exemestane, as well as Nufex Beta QugylO Immunotec. Adding to it, during the year 2009-2010, 11 new products across a range of therapeutic segments were launched, such as Demator Sizomax Mela Exinia and Mofetyl S, and they also launched a new immunosuppressant product Sirolimus during the same year. New divisions in the highly growing chronic segments Cardiology, Diabetic, Neurology-Psychiatry, Oncology were also launched. The Company sold its Biotech Unit located at Ankleshwar to M/s. Intas Pharmaceuticals Limited as a going concern in 2016-2017 and acquired 7 brands from Sun Pharmaceuticals Limited the same year. In 2017-2018, the Company launched two new brands Darbepoetin and RituximabXMAB in the post-transplant care space. It also launched a new product TJAKi JAK Inhibitor in the immunosuppressant range of products in Rheumatology and Gastroenterology in FY21, and Azoran 75 mg new line extension was also launched in 2021. Naprosyn and AldactoneF were launched in FY22.

Share Price: ₹2653.00 per share as on 07 Nov, 2024 04:01 PM
Market Capitalisation: ₹4,422.37Cr as of today
Listing date: 10 Jun, 2008
Chairperson Name: H V Goenka
OrganisationRPG Life Sciences Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for RPG Life Sciences Ltd

  • RPG Life Sciences Prepares for Q2 Earnings Release - 31 Oct, 2024

    RPG Life Sciences is set to announce its Q2 results on November 7, 2024. The stock gained 2.52% on October 31, closing at Rs 2505.45. Year-to-date, shares are up 88%, with impressive long-term returns.

Insights on RPG Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RPGLIFE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RPGLIFE has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.14% to 1.35% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.65% to 2.67% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, RPGLIFE stock has moved up by 87.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.81% of holdings in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.42% to 20.39% in Sep 2024 quarter

RPG Life Sciences Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹312.41Cr (-)₹350.33Cr (↑12.14%)₹424.08Cr (↑21.05%)₹518.29Cr (↑22.22%)
Total Liabilities₹95.96Cr (-)₹94.56Cr (↓1.46%)₹116.48Cr (↑23.18%)₹143.44Cr (↑23.15%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹50.17Cr (-)₹58.27Cr (↑16.15%)₹64.75Cr (↑11.12%)₹90.82Cr (↑40.26%)₹94.36Cr (↑3.90%)

Index Inclusions

BSE Healthcare

₹44,101.33

-0.85 (-377.93%)

BSE Small-Cap

₹55,764.08

-0.44 (-244.05%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

RPG Life Sciences Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
72.81%
0.00
Foreign Institutions
1.35%
17.65
Mutual Funds
2.67%
61.58
Retail Investors
20.39%
-4.80
Others
2.78%
-6.45

RPG Life Sciences Ltd Key Indicators

Details20202021202220232024
Return On Equity %19.5420.3621.824.0125.69

RPG Life Sciences Ltd Earnings and Dividends

  • RPG Life Sciences Ltd Earnings Results

    RPG Life Sciences Ltd’s net profit jumped 21.09% since last year same period to ₹26.76Cr in the Q1 2024-2025. On a quarterly growth basis, RPG Life Sciences Ltd has generated 102.11% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • RPG Life Sciences Ltd Dividends April,2024

    In the quarter ending March 2024, RPG Life Sciences Ltd has declared dividend of ₹16 - translating a dividend yield of 0.60%.

    Read More about Dividends

RPG Life Sciences Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

RPG Life Sciences Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on RPG Life Sciences Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy RPG Life Sciences Ltd shares.

RPG Life Sciences Ltd (RPGLIFE) share price today is ₹2653

RPG Life Sciences Ltd is listed on NSE

RPG Life Sciences Ltd is listed on BSE

  • Today’s highest price of RPG Life Sciences Ltd is ₹2728.7.
  • Today’s lowest price of RPG Life Sciences Ltd is ₹2623.95.

Today’s traded volume of RPG Life Sciences Ltd(RPGLIFE) is 11.95K.

Today’s market capitalisation of RPG Life Sciences Ltd(RPGLIFE) is ₹4422.37Cr.

RPG Life Sciences Ltd(RPGLIFEPrice
52 Week High
₹2974.95
52 Week Low
₹1292

RPG Life Sciences Ltd(RPGLIFE) share price is ₹2653. It is down -10.82% from its 52 Week High price of ₹2974.95

RPG Life Sciences Ltd(RPGLIFE) share price is ₹2653. It is up 105.34% from its 52 Week Low price of ₹1292

RPG Life Sciences Ltd(RPGLIFEReturns
1 Day Returns
-20.9%
1 Month Returns
0.65%
3 Month Returns
37.09%
1 Year Returns
84.43%